Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases-Reference-Cited by-同舟云学术

Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases

Published:2009-03 Issue:6 Volume:19 Page:1718-1721
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Hubbard Robert D.,Bamaung Nwe Y.,Fidanze Steve D.,Erickson Scott A.,Palazzo Fabio,Wilsbacher Julie L.,Zhang Qian,Tucker Lora A.,Hu Xiaoming,Kovar Peter,Osterling Donald J.,Johnson Eric F.,Bouska Jennifer,Wang Jieyi,Davidsen Steven K.,Bell Randy L.,Sheppard George S.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference16 articles.

1. Role of Tyrosine Kinase Inhibitors in Cancer Therapy

2. TYROSINE KINASE INHIBITORS AND THE DAWN OF MOLECULAR CANCER THERAPEUTICS

3. Strategies to overcome resistance to targeted protein kinase inhibitors

4. Insulin-like growth factor ligands, receptors, and binding proteins in cancer

5. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress of Benzimidazole Hybrids for Anticancer Potential;Current Medicinal Chemistry;2020-10-28

2. SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors;SAR and QSAR in Environmental Research;2017-02-01

3. Novel Aryl‐Modified Benzoylamino‐ N ‐(5,6‐dimethoxy‐1H‐benzoimidazol‐2‐yl)‐heteroamides as Potent Inhibitors of Vascular Endothelial Growth Factor Receptors 1 and 2;Journal of Heterocyclic Chemistry;2016-12-11

4. 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFRL858R/T790M;Bioorganic & Medicinal Chemistry Letters;2015-10

5. QSAR-Based Models for Designing Quinazoline/Imidazothiazoles/Pyrazolopyrimidines Based Inhibitors against Wild and Mutant EGFR;PLoS ONE;2014-07-03